Prior to joining AMRI in December 2019, John Ratliff served as Chief Executive Officer of Covance Drug Development, the world’s most comprehensive drug development company. He is a highly respected biopharmaceutical leader, with extensive experience in increasingly influential roles in the industry. In 2018, Ratliff was appointed Chairman for the Association of Clinical Research Organizations.

Previously John was president and CEO of HUYA Bioscience International. His healthcare industry experience also includes almost 10 years at Quintiles, the world’s largest provider of product development and integrated healthcare services, where he served as Chief Financial Officer before becoming President and Chief Operating Officer. He was a member of the Quintiles board of directors.  Prior roles throughout his career included CFO at Acterna, a provider of communications test solutions for telecommunications and cable network operators, and positions of increasing responsibility during his 19-year tenure at IBM.

Ratliff holds a bachelor’s degree in industrial and systems engineering, highest honors, from the Georgia Institute of Technology in Atlanta and serves on the Georgia Tech Advisory BOD. He also received his master’s degree in business administration from Duke University in Durham, North Carolina.

John Ratliff